S
Stemcentrx
Develops innovative therapies for cancer
At a glance
- Founded
- 2008
- Headquarters
- South San Francisco, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
- CGCapital Group
- AVArtis Ventures
Sequoia- JHJames Hong
Founders Fund
Silicon Valley Bank
Fidelity Investments
Source: Dealroom Talent Intelligence.
Alumni founders
Former Stemcentrx employees who went on to found companies, sorted by Dealroom signal score.
ETEnliven TherapeuticsEst. 2019
Sam KintzUnited States
INInterVennEst. 2017
Lieza MarieUnited States
PRProfoundBioEst. 2018
ZIZitaraEst. 2019
Evan MurphyUnited StatesGlobal footprint
team presence
Patents
19 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stemcentrx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stemcentrx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.